Mead Johnson, a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in over 50 markets worldwide. The company's mission is to nourish the world's children for the best start in life. The Mead Johnson name has been associated with science-based pediatric nutrition products for over 100 years. The company's `Enfa` family of brands, including Enfamil? infant formula, is the world's leading brand franchise in pediatric nutrition.
Industry sector: Consumer Staples
Sector classification: Food & kindred products
Deep Learning based analysis and prediction model for Mead Johnson Nutrition Company (MJN) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.
Model is in the production pipeline since Sept. 30, 2015.
Market data for MJN model training are being downloaded from the Quandl premium datasets on a daily basis.
Model is being retrained on a daily basis.
|% Held by Insiders||0.50%|
|% Held by Institutions||88.40%|
|EPS (last reported FY)||$3.40|
|EPS (last reported Q)||$0.80|
|EPS, estimated (last reported Q)||$0.82|
|Total revenues||$4 B|
|Net income||$1 B|